Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 2
1984 6
1985 8
1986 7
1987 6
1988 6
1989 7
1990 6
1991 4
1992 1
1993 4
1994 2
1995 3
1996 3
1997 8
1998 3
1999 6
2000 10
2001 14
2002 11
2003 15
2004 16
2005 11
2006 8
2007 16
2008 21
2009 10
2010 7
2011 14
2012 11
2013 9
2014 11
2015 17
2016 12
2017 7
2018 7
2019 4
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

288 results
Results by year
Filters applied: . Clear all
Page 1
Platelet gel: a new therapeutic tool with great potential.
Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M, Gentilini I, Eisendle K, Fontanella F. Piccin A, et al. Among authors: gastl g. Blood Transfus. 2017 Jul;15(4):333-340. doi: 10.2450/2016.0038-16. Epub 2016 Jul 25. Blood Transfus. 2017. PMID: 27483482 Free PMC article. Review.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Gisslinger H, Zagrijtschuk O, Buxhofer-Ausch V, Thaler J, Schloegl E, Gastl GA, Wolf D, Kralovics R, Gisslinger B, Strecker K, Egle A, Melchardt T, Burgstaller S, Willenbacher E, Schalling M, Them NC, Kadlecova P, Klade C, Greil R. Gisslinger H, et al. Among authors: gastl ga. Blood. 2015 Oct 8;126(15):1762-9. doi: 10.1182/blood-2015-04-637280. Epub 2015 Aug 10. Blood. 2015. PMID: 26261238 Free PMC article. Clinical Trial.
Targeted Therapy of Colorectal Cancer.
Seeber A, Gastl G. Seeber A, et al. Among authors: gastl g. Oncol Res Treat. 2016;39(12):796-802. doi: 10.1159/000453027. Epub 2016 Nov 22. Oncol Res Treat. 2016. PMID: 27889786 Review.
Austrian recommendations for the management of polycythemia vera.
Burgstaller S, Buxhofer-Ausch V, Sliwa T, Beham-Schmid C, Gastl G, Geissler K, Melchardt T, Krauth M, Krippl P, Petzer A, Rumpold H, Wölfler A, Gisslinger H. Burgstaller S, et al. Among authors: gastl g. Wien Klin Wochenschr. 2018 Sep;130(17-18):535-542. doi: 10.1007/s00508-018-1359-3. Epub 2018 Jul 19. Wien Klin Wochenschr. 2018. PMID: 30027395 Review.
Treg(s) in Cancer: Friends or Foe?
Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM. Wolf D, et al. Among authors: gastl g. J Cell Physiol. 2015 Nov;230(11):2598-605. doi: 10.1002/jcp.25016. J Cell Physiol. 2015. PMID: 25913194 Review.
Hematopoietic stem cells.
Gunsilius E, Gastl G, Petzer AL. Gunsilius E, et al. Among authors: gastl g. Biomed Pharmacother. 2001 May;55(4):186-94. doi: 10.1016/s0753-3322(01)00051-8. Biomed Pharmacother. 2001. PMID: 11393804 Review.
Current treatment concepts of Philadelphia-negative MPN.
Wolf D, Rudzki J, Gastl G. Wolf D, et al. Among authors: gastl g. Curr Cancer Drug Targets. 2011 Jan;11(1):44-55. doi: 10.2174/156800911793743592. Curr Cancer Drug Targets. 2011. PMID: 21062242 Review.
[Palliative immunotherapy of cancer].
Gunsilius E, Clausen J, Gastl G. Gunsilius E, et al. Among authors: gastl g. Ther Umsch. 2001 Jul;58(7):419-24. doi: 10.1024/0040-5930.58.7.419. Ther Umsch. 2001. PMID: 11508110 Review. German.
The kinase inhibitor imatinib--an immunosuppressive drug?
Wolf D, Tilg H, Rumpold H, Gastl G, Wolf AM. Wolf D, et al. Among authors: gastl g. Curr Cancer Drug Targets. 2007 May;7(3):251-8. doi: 10.2174/156800907780618293. Curr Cancer Drug Targets. 2007. PMID: 17504122 Review.
New insights into sinusoidal obstruction syndrome.
Piccin A, Sartori MT, Bisogno G, Van Schilfgaarde M, Saggiorato G, Pierro AMD, Corvetta D, Marcheselli L, Mega A, Gastl G, Cesaro S. Piccin A, et al. Among authors: gastl g. Intern Med J. 2017 Oct;47(10):1173-1183. doi: 10.1111/imj.13550. Intern Med J. 2017. PMID: 28707749
288 results